Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T17:06:59.676Z Has data issue: false hasContentIssue false
  • English
  • Français

The Control of Deviant Sexual Behaviour by Drugs

I. Behavioural changes following Oestrogens and Anti-Androgens

Published online by Cambridge University Press:  29 January 2018

John Bancroft ,
Gavin Tennent ,
Kypros Loucas  and
James Cass
John Bancroft
Affiliation:
Department of Psychiatry, University of Oxford, The Warneford Hospital, Oxford, OX3 7JX
Gavin Tennent*
Affiliation:
Special Hospitals Reseach Unit
Kypros Loucas
Affiliation:
Broadmoor Hospital, Crowthorne, Berks
James Cass
Affiliation:
Broadmoor Hospital, Crowthorne, Berks
*
∗Now Medical Director, St. Brendan's Hospital, Bermuda.
Get access Rights & Permissions [Opens in a new window]

Extract

Drugs have been used to control deviant sexual behaviour in recidivist sexual offenders for over 20 years. Oestrogens have been most widely used (Golla and Hodge, 1949; Whittaker, 1959; Scott, 1964) and generally have been considered to be effective though limited by their side effects, in particular nausea, vomiting and feminization. A further uncommon but grave complication has been carcinoma of the breast (Symmers, 1968). Recently, oestradiol implants have been used (Field and Williams, 1970). A similar libido-reducing effect has been claimed with some tranquillizers, notably thioridazine (Litkey and Feniczy, 1967; Bartholomew, 1964), fluphenazine enanthate (Bartholomew, 1964) and a new butyrophenone, benperidol (Sterkmans and Geerts, 1966; Field, 1973). Progestogens have been recognized for some time as having libido reducing qualities in both males and females (Heller et al., 1958; Kupperman, 1963; Money, 1970). The use of medroxyprogesterone in treating sexual deviants has recently been reported (Money, 1970); it was found not only to be effective in controlling behaviour but also to produce marked reduction in circulating androgen. Currently, much interest is being shown in the use of an anti-androgen, cyproterone acetate, for this purpose (Laschet and Laschet, 1969; Briggs and Briggs, 1971; Cooper et al., 1972).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 125 , Issue 586 , September 1974 , pp. 310 - 315
Copyright
Copyright © Royal College of Psychiatrists, 1974 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

A synopsis of this paper was published in the July 1974 Journal.

References

Bancroft, J. H. J. (1971) The application of psychophysiological measures to the assessment and modification of sexual behaviour. Behaviour Research and Therapy, 9, 119—30.Google Scholar
Bancroft, J. H. J., Jones, H. G. & Pullen, B. R. (1966) A simple transducer for measuring penile erection, with comments on its use in the treatment of sexual disorders. Behaviour Research & Therapy, 4, 239—41.CrossRefGoogle ScholarPubMed
Bartholomew, A. A. (1964) Some side effects of thioridazine. Medical Journal of Australia, 1, 57.Google Scholar
Bartholomew, A. A. (1968) A long acting phenothiazine as a possible agent to control deviant sexual behaviour. American Journal of Psychiatry, 124, 917—23.CrossRefGoogle Scholar
Briggs, M. & Briggs, M. H. (1971) The treatment of male hypersexual conditions by a non-oestrogenic anti-androgen. Medical Journal of Zambia, 5, 125—9.Google Scholar
Cochran, W. G. & Cox, D. R. (1957) Experimental Designs, 2nd edition. New York: Loxley.Google Scholar
Cooper, A. J., Ismail, A. A. A., Phanjoo, A. L. & Love, D. L. (1972) Anti-androgen (cyproterone acetate) therapy in deviant hypersexuality. British Journal of Psychiatry, 120, 59—64.CrossRefGoogle ScholarPubMed
Field, L. H. (1973) Benperidol in the treatment of sex offenders. Medicine, Science and the Law, 13, 195.Google Scholar
Field, L. H. & Williams, M. (1970) The hormonal treatment of sexual offenders. Medicine, Science and the Law, 10, 27.Google Scholar
Golla, F. L. & Hodge, S. R. (1949) Hormone treatment of sex offenders. Lancet, i, 1006.CrossRefGoogle Scholar
Heller, C. G., Laidlaw, W. M., Harvey, H. T. & Nelson, D. L. (1958) Effects of progestational compounds on the reproductive processes of the human male. Annals of the New York Academy of Sciences, 71, 649—65.CrossRefGoogle ScholarPubMed
Kupperman, H. S. (1963) Human Endocrinology, p. 397. Philadelphia: Davis.Google Scholar
Laschet, V. & Laschet, L. (1969) Three years clinical results with cyproterone acetate in the inhibiting regulation of male sexuality. Acta Endocrinologica, 138, Suppl. 232.Google Scholar
Litkey, L. J. & Feniczy, P. (1967) An approach to the control of homosexual practices. International Journal of Neuropsychiatry, 3, 20—23.Google Scholar
Marks, I. M. & Sartorius, N. (1968) A contribution to the measurement of sexual attitudes. Journal of Nervous and Mental Diseases, 145, 441—51.Google Scholar
Money, J. (1970) Use of an androgen-depleting hormone in the treatment of male sex offenders. Journal of Sex Research, 6, 165—72.Google Scholar
Murray, M. A. F., Bancroft, J. H. J., Tennent, T. G., Carr, P. J. & Anderson, D. C. (1974) The control of deviant sexual behaviour by drugs. II. Endocrine changes following oestrogens, anti-androgens and tranquillisers (in preparation).Google Scholar
Scott, P. D. (1964) Definition, classification, prognosis and treatment. In Pathology and Treatment of Sexual Deviation (ed. Rosen, I.). Oxford University Press.Google Scholar
Sterkmans, P. & Geerts, F. (1966) Is benperidol (RF504) the specific drug for the treatment of excessive and disinhibited sexual behaviour? Acta Neurologica et Psychiatrica Belgica, 66, 1030—40.Google Scholar
Symmers, W. St. C. (1968) Carcinoma of breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. British Medical Journal, ii, 83—5.Google Scholar
Tennent, G., Bancroft, J. H. J. & Cass, J. (1974) The control of deviant sexual behaviour by drugs: a double blind controlled study of benperidol, chlorpromazine and placebo. Archives of Sexual Behaviour (in press).CrossRefGoogle Scholar
Weiner, B. J. (1962) Statistical Principles in Experimental Design. New York: McGraw-Hill.Google Scholar
Whittaker, L. H. (1959) Oestrogens and psychosexual disorders. Medical Journal of Australia, ii, 547.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.